This cell-like structure can grow, feed, divide and compete. Researchers ponder what it means for the future of synthetic ...

Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...

Phase 2b Elumina trial; topline data anticipated in Q4 2026 (ClinicalTrials.gov: NCT06524830) AtaiBeckley plans to advance VLS-01 into major depressive disorder (MDD) in Phase 3, with generalized ...

The Council has agreed its position on a proposed directive that updates the rules on genetically modified micro-organisms ...

Humanmaxxing is the latest wellness trend focused on maximizing human potential through biohacking, longevity science and ...

Continuous bioprocessing PAT requires real-time sensors and closed-loop control to maintain steady-state culture conditions.

IMU Biosciences, a biotechnology company decoding the immune system to pioneer a paradigm shift in how we understand, diagnose, and treat disease, and Waters Corporation (NYSE: WAT) today announced a ...

The airwaves are crackling this week with news of the first synthetic cell, constructed and cultured by researchers from the ...

Fatty15 reports metabolic health is more important than weight loss, focusing on factors like blood sugar and cholesterol, ...

But New Zealand is doing far more than failing to stop US and Israeli criminality. Instead, NZ is providing material enhancement to the war fighting abilities of those countries. The NZDF regularly ...

Detailed price information for Nasdaq Biotechnology Ishares ETF (IBB-Q) from The Globe and Mail including charting and trades ...

IMU Biosciences partners with Waters to advance IMU’s AI-driven immunology platform to transform diagnosis and monitoring: London, UK Friday, June 26, 2026, 12:00 Hrs [IST] IMU ...